Facebook Twitter email LinkIN YouTube Pinterest
Iconsline

Logo textLogo africa

In this episode we travel to Nigeria and Kenya to explore how a leading healthcare company is supporting access to healthcare. This story demonstrates what’s possible when public and private sectors combine with the shared goal of improving lives through access to quality care.

Prohibitive costs, geographic isolation and a lack of basic information result in illness, disability and death for far too many Africans, but medical intervention programmes supported by the private sector mean that millions stand the chance of enjoying healthy, productive lives.

To see these programmes in action we travelled to Nigeria to visit the Obafemi Awolowo University Teaching Hospital, a few hours’ drive north of Lagos, where a Novartis supported oncology access programme has already saved hundreds of lives through screening, early detection and treatment. Then we journeyed to Kirinyaga County in Kenya to find out about the Familia Nawiri community screening and education programme. We completed our trip at Kenya’s Nairobi Hospital where we met and interviewed medical specialists and those benefiting from corporate supported programmes focused on access to quality, life-saving healthcare.

Lives are being changed through shared effort. That‘s what IT’S AFRICA’S TIME is all about.

Gallery

  • A GIPAP patient collects his free Novartis medication at Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria
  • Blood donation board, Obafemi Awolowo Univeristy Teaching Hospital, Ile Ife, Nigeria
  • Cameraman, Jasyn Howes, films a GIPAP patient consultation at Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria
  • Doctors at Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria
  • Dr Adeola Adeniyi, Resident Obafemi Awolowo Univeristy Teaching Hospital 3
  • Filming a bone marrow biopsy, Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria
  • Lab technician at Obafemi Awolowo Univeristy Teaching Hospital, Haematology Unit, Ile Ife, Nigeria
  • Nurse at Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria 1
  • Nurses at Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria
  • Obafemi Awolowo Univeristy Teaching Hospital, Ile Ife, Nigeria
  • Obafemi Awolowo University Teaching Hospital ward, Ile Ife, Nigeria 1
  • Obafemi Awolowo University Teaching Hospital ward, Ile Ife, Nigeria 4
  • Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria 2
  • Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria 4
  • Professor Muheez Durosinmi, Co-ordinator, GIPAP Programme, Nigeria
  • Resident doctors at a session at Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria 2

More

 

 




Full Story

Season2VideoFrame


NovartisSeason3Header

Vignettes LongLine

S3E8V1 spacer  S3E8V2 spacer S3E8V3
Novartis and the Obafemi Awolowo Teaching Hospital
Accessing quality healthcare is a huge challenge for Africans across the continent. Novartis is partnering with a teaching hospital haematology unit in Nigeria to supply a drug to patients living with a rare form of leukaemia and stomach cancer.
 
Novartis and the Familia Nawiri Program
In Africa access to quality healthcare is an ongoing challenge and a burden to economic growth. Novartis supports the Familia Nawiri program which provides mobile health clinics, screenings and diagnostics services to rural Kenyan communities.
 
Novartis, Improving Lives Through Access To Healthcare
Novartis partners with hospitals in Nigeria and Kenya and are giving them lifesaving medication for patients with rare forms of cancer. They also support rural mobile health clinics providing preventative screening, diagnosis and medication.

This is what’s possible when public and private sectors combine with the shared goal of improving lives through access to healthcare.

Novartis